Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Big Pharma Biotechnology and Pharmaceuticals Bristol Myers Squibb business Cancer Clinical trial conference Deal Eli Lilly European Commission European Union Facebook FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News
Category Archives: Emerging Markets
Witty Proposes Price Cap for Poor Nations
GlaxoSmithKline CEO Andrew Witty proposed Friday to slash drug prices in the world’s 50 poorest countries and reinvest 20 percent of the profits in bolstering local health care. In a speech at Harvard Medical School Friday, Witty said drug prices will be capped at 25 percent of what they cost in developed nations. He also [...]
Also posted in Corporate Responsibility, People Tagged Andrew Witty, asthma, GSK, malaria Leave a comment
Gilead Making a Bundle
Gilead Sciences has once again proven that independent biotechs can innovate with the best of Big Pharma. The Silicon Valley company’s wizardry at weaving multiple drugs into a single weft enabled it to overthrow GlaxoSmithKline as king of HIV in 2007. Yesterday, at the 16th annual Congress of Retroviruses and Opportunistic Infections (CROI), the biotech [...]
Amid Big Pharma Woes, Shire in “Best Shape Everâ€
Angus Russell, Shire’s longtime CFO—now CEO—likens the failing US automobile industry to pharma. “All the problems with the automobile industry were a long time coming,†he says. “It’s just that the SUVs and the relatively cheap price of gas created a bubble, just like a booming economy and blockbusters.â€
But now that the bubble has burst, [...]
The Real China Strategy
There’s a lot of talk these days about India and China as potential markets and as sources for cheap manufacturing and R&D. But the real potential of these countries is far more interesting: As China and India (and Brazil, Russia, and Korea) learn to create new products, they’re going to do it at price [...]
Also posted in Biotech, Deals, Strategy Tagged Abe Abuchowski, Biotech, China, PEGylation, Pharma, Prolong 8 Comments

US and Europe At Risk from Substandard Medicines